8 Universal LCMS-based assay platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeutics using one reference antibody

Noriko Iwamoto; Yoshinobu Koguchi; Kotoko Yokoyama; Akinobu Hamada; Atsushi Yonezawa; Brian Piening; Eric Tran; Bernard Fox; William Redmond; Takashi Shimada

doi:10.1136/jitc-2022-SITC2022.0008

Article info

Regular and Young Investigator Award Abstracts

Biomarkers, Immune Monitoring and Novel Technologies

8 Universal LCMS-based assay platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeutics using one reference antibody

Free

Authors

Noriko Iwamoto Shimadzu Corporation, Kyotoi, Japan PubMed articles Google scholar articles
Yoshinobu Koguchi Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Kotoko Yokoyama Shimadzu Corporation, Kyotoi, Japan PubMed articles Google scholar articles
Akinobu Hamada National Cancer Center Research Institute, Tokyo, Japan PubMed articles Google scholar articles
Atsushi Yonezawa Kyoto University Hospital, Kyoto, Japan PubMed articles Google scholar articles
Brian Piening Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Eric Tran Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Bernard Fox Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
William Redmond Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Takashi Shimada Shimadzu Corporation, Kyotoi, Japan PubMed articles Google scholar articles

Citation

Iwamoto N, Koguchi Y, Yokoyama K, et al

8 Universal LCMS-based assay platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeutics using one reference antibody

Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.0008

Publication history

First published November 7, 2022.

Online issue publication

April 26, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password